WILMINGTON, Delaware --A federal jury of eight will continue on Friday deliberations begun late Thursday on Oxford Gene Technology's allegation that Affymetrix's (AFFX) GeneChip product infringes on ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics ® Corporation for $15 ...

SAN DIEGO & SANTA CLARA, Calif., Jan 10, 2008 - Affymetrix and Illumina, Inc. (NASDAQ:ILMN) announced today that they have entered into a settlement agreement to resolve their patent litigation. Under ...

Shares jump after the company's board approves a buyout offer from Thermo Fisher Scientific. So what: This transaction should help to grow Thermo's footprint in the red-hot area of biogenetic analysis ...

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2012. Total revenue for the quarter was $66.4 million, including approximately $1.4 million in revenue ...

Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) announced the launch of the new OncoScan™ FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor ...

Can a single word in a 35,000-word merger agreement cause a buyer to lose a deal to a higher bidder? In the case of Thermo Fisher Scientific Inc.’s pending buyout of Affymetrix Inc., it’s possible.

Affymetrix' management team will host a conference call on April 27, 2011 at 2:00 p.m. PT to review its operating results for the first quarter of 2011. A live webcast can be accessed by visiting the ...

There's no foolproof way to know the future for Affymetrix (NAS: AFFX) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock ...